You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm will use the proceeds for working capital and other general corporate purposes, with the potential to acquire or invest in complementary businesses, technologies, or assets.
The PCR viral load test runs on the Cobas 6800/8800 systems and has been calibrated to the World Health Organization International Standard, Roche said.
The tests use a range of different specimens including self-collected nasal swabs, bronchoalveolar lavage, sputum, and nasopharyngeal washes.
The firm generated $46.2 million in revenues compared to $53.5 million in the prior year, which was better than analysts' estimate of $39.6 million.
The genetic testing company said its orders for traditional tests have also rebounded and are on track for growth in the second half of 2020.
GenMark has two SARS-CoV-2 tests that have received FDA Emergency Use Authorization, including a respiratory panel that tests for 21 pathogens.
The company posted Q2 revenues of $13.1 million, down from $13.5 million in Q2 2019 but above the consensus Wall Street estimate of $11.8 million.
The firm delivered record revenue and the most profitable quarter in its history as a result of the increased demand for its products.
On an adjusted basis at constant exchange rates, revenues grew 19 percent year over year, in line with guidance provided by the company in early July.
The company reported $41.8 million in total revenues for the quarter and said testing services revenues rose 41 percent year over year.
Coastal Genomics owns the Ranger gel electrophoresis technology to collect specific DNA target sizes, with applications in noninvasive prenatal testing and oncology.
The index significantly outperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index in July.
Fluidigm's Helios mass cytometer and Hyperion imaging system will be bundled with De Novo's FCS Express 7 Flow software for suspension data analysis.
Genuity, formerly known as WuXi NextCode, will sequence, analyze, and harmonize samples from Vanderbilt's biobank to inform biomarker and drug discovery.
The firm said that its Diagnostics and Genomics segment sales were essentially flat, while its Protein Sciences segment sales were down 11 percent during Q4.
The sequencing firm said the COVID-19 pandemic had a negative impact on revenues, which totaled $17.1 million, down from $24.6 million in the prior-year period.
The company reported Q2 revenues of $424.6 million, down from $490.2 million in Q2 2019 but beating the consensus Wall Street estimate of $390.9 million.
The court also ordered a new trial to determine if 10x's products infringe reconstructed patents held by Bio-Rad Laboratories.
The team will launch a Phase II study to validate early-stage gastric cancer micro-RNA biomarkers and eventually develop liquid biopsy tests.
Metabolon's Precision Metabolomics platform identifies pharmacodynamic, efficacy, and response biomarkers and tracks changes in biological pathways.
The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.
According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.
NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.
In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.